The global endoscopy devices market size was estimated to be USD 46.23 billion in 2023 and is expected to reach at USD 107.6 billion by 2033 with a CAGR of 7.98% during the forecast period 2023-2033. Growing demand for less invasive procedures, rising adoption of disposable endoscopic components, increasing prevalence of chronic diseases, surge in technological advancements, growing geriatric population, rising reimbursement policies, surge in product approvals by U.S. Food and Drug Administration (FDA), and increasing launch of innovative advanced endoscopes are some of the key factors boosting the market growth.
Increasing launch of innovative advanced endoscopes is predicted to boost the market growth during the forecast period. For instance, in August 2021, Fujifilm Holdings Corporation has introduced the ELUXEO 7000X endoscopic Imaging System, which allows for immediate visualization of tissue's haemoglobin oxygen saturation (StO2) levels during laparoscopic and/or endoluminal imaging procedures.
By Product, Endoscopy visualization was the highest revenue-grossing segment in the global endoscopy devices market in 2022 owing to the growing adoption of endoscopy visualization during endoscopy procedures, increasing need of diagnosis of complex disease conditions such as cancer, urinary disorders, GI disorders, and lung disorders, rising adoption of minimally invasive procedures, and surge in demand for next-generation endoscopy visualization systems. Additionally, Endoscopes is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of endoscopic procedures, rising adoption of flexible endoscopes to perform surgeries & biopsies for better diagnosis & treatment, increasing prevalence of chronic diseases, and growing product approvals by regulatory bodies. For instance, in August 2021, The FDA has granted approval to Boston Scientific for the EXALT Model B Single-Use Bronchoscope. This innovative bronchoscope represents the latest advancement in flexible bronchoscopy and is specifically designed for use in the ICU. Its purpose is to assist in maintaining clear airways during intricate respiratory procedures such as double-lumen tube placements.
By Application, Gastrointestinal (GI) endoscopy was the highest revenue-grossing segment in the global endoscopy devices market in 2022 owing to the growing geriatric population, increasing prevalence of functional gastrointestinal diseases, surge preference for endoscopy procedure as first-line treatment for early detection & diagnosis of functional gastrointestinal disorders, rising demand for technologically advanced endoscopes, increasing focus on development of technologically advanced endoscopy systems, and growing launch of advanced products. For instance, in November 2021, FUJIFILM Healthcare has introduced a dual-channel endoscope that has received clearance from the United States Food and Drug Administration for both upper and lower gastrointestinal applications. Additionally, the urology endoscopy is predicted to grow at fastest CAGR during forecast period owing to the rising prevalence of chronic urological diseases such as bladder cancer and increasing number of cystoscopy procedures.
By End-user, Hospitals was the highest revenue-grossing segment in the global endoscopy devices market in 2022 owing to the rising preference of hospitals for the diagnosis and treatment of chronic disorders, increase in number of surgeries performed in hospitals including endoscopy procedures, growing adoption of endoscopy devices, rising initiatives by market players, and surge in introduction of advanced products for effective disease management. For instance, in September 2020, PENTAX Medical has revealed plans to introduce the J10 Series of Ultrasound Video Gastroscopes in the United States. These state-of-the-art gastroscopes offer improved image quality, enhanced diagnostic capabilities, and assist in the effective management of patients' conditions. Additionally, Ambulatory surgery centers/clinics is predicted to grow at fastest CAGR during the forecast period owing to the increasing preference for minimally invasive procedures, rising adoption of endoscopy devices in ambulatory surgery centers/clinics, and growing technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, & functional gastrointestinal disorders, growing geriatric population, rising awareness for early disease diagnosis, surge in minimally invasive procedures, growing healthcare infrastructure, and increasing launch of technologically advanced devices. For instance, in July 2021, Smith & Nephew Plc has released a Robot-assisted endoscope called the Real Intelligence Suite, consisting of advanced technology solutions such as the next-generation robotics platform and the CORI Surgical System. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of functional gastrointestinal disorder, rising demand for minimally invasive endoscopic procedure, growing healthcare infrastructure, increasing government initiatives, and surge in product approvals by regulatory bodies. For instance, in August 2022, Medtronic has introduced GI Genius, an artificial intelligence endoscopy module, in India for the treatment of colorectal cancer. This innovative medical solution provides real-time data and enables physicians to identify and address colorectal cancer, providing improved visualization during colonoscopy procedures.
Increasing launch of innovative advanced endoscopes is predicted to boost the market growth during the forecast period. For instance, in August 2021, Fujifilm Holdings Corporation has introduced the ELUXEO 7000X endoscopic Imaging System, which allows for immediate visualization of tissue's haemoglobin oxygen saturation (StO2) levels during laparoscopic and/or endoluminal imaging procedures.
By Product, Endoscopy visualization was the highest revenue-grossing segment in the global endoscopy devices market in 2022 owing to the growing adoption of endoscopy visualization during endoscopy procedures, increasing need of diagnosis of complex disease conditions such as cancer, urinary disorders, GI disorders, and lung disorders, rising adoption of minimally invasive procedures, and surge in demand for next-generation endoscopy visualization systems. Additionally, Endoscopes is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of endoscopic procedures, rising adoption of flexible endoscopes to perform surgeries & biopsies for better diagnosis & treatment, increasing prevalence of chronic diseases, and growing product approvals by regulatory bodies. For instance, in August 2021, The FDA has granted approval to Boston Scientific for the EXALT Model B Single-Use Bronchoscope. This innovative bronchoscope represents the latest advancement in flexible bronchoscopy and is specifically designed for use in the ICU. Its purpose is to assist in maintaining clear airways during intricate respiratory procedures such as double-lumen tube placements.
By Application, Gastrointestinal (GI) endoscopy was the highest revenue-grossing segment in the global endoscopy devices market in 2022 owing to the growing geriatric population, increasing prevalence of functional gastrointestinal diseases, surge preference for endoscopy procedure as first-line treatment for early detection & diagnosis of functional gastrointestinal disorders, rising demand for technologically advanced endoscopes, increasing focus on development of technologically advanced endoscopy systems, and growing launch of advanced products. For instance, in November 2021, FUJIFILM Healthcare has introduced a dual-channel endoscope that has received clearance from the United States Food and Drug Administration for both upper and lower gastrointestinal applications. Additionally, the urology endoscopy is predicted to grow at fastest CAGR during forecast period owing to the rising prevalence of chronic urological diseases such as bladder cancer and increasing number of cystoscopy procedures.
By End-user, Hospitals was the highest revenue-grossing segment in the global endoscopy devices market in 2022 owing to the rising preference of hospitals for the diagnosis and treatment of chronic disorders, increase in number of surgeries performed in hospitals including endoscopy procedures, growing adoption of endoscopy devices, rising initiatives by market players, and surge in introduction of advanced products for effective disease management. For instance, in September 2020, PENTAX Medical has revealed plans to introduce the J10 Series of Ultrasound Video Gastroscopes in the United States. These state-of-the-art gastroscopes offer improved image quality, enhanced diagnostic capabilities, and assist in the effective management of patients' conditions. Additionally, Ambulatory surgery centers/clinics is predicted to grow at fastest CAGR during the forecast period owing to the increasing preference for minimally invasive procedures, rising adoption of endoscopy devices in ambulatory surgery centers/clinics, and growing technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, & functional gastrointestinal disorders, growing geriatric population, rising awareness for early disease diagnosis, surge in minimally invasive procedures, growing healthcare infrastructure, and increasing launch of technologically advanced devices. For instance, in July 2021, Smith & Nephew Plc has released a Robot-assisted endoscope called the Real Intelligence Suite, consisting of advanced technology solutions such as the next-generation robotics platform and the CORI Surgical System. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of functional gastrointestinal disorder, rising demand for minimally invasive endoscopic procedure, growing healthcare infrastructure, increasing government initiatives, and surge in product approvals by regulatory bodies. For instance, in August 2022, Medtronic has introduced GI Genius, an artificial intelligence endoscopy module, in India for the treatment of colorectal cancer. This innovative medical solution provides real-time data and enables physicians to identify and address colorectal cancer, providing improved visualization during colonoscopy procedures.
Segmentation: Endoscopy Devices Market Report 2022 - 2033
Endoscopy Devices Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)
Endoscopes
- Capsule Endoscope
- Flexible Endoscope
- Robot-assisted Endoscope
- Rigid Endoscope
Endoscopic Operative Device
- Access Device
- Insufflation Device
- Wound Protector
- Irrigation/Suction System
- Operative Manual Instrument
- Others
Visualization Equipment
- Endoscopic Camera
- HD Visualization System
- SD Visualization System
Endoscopy Devices Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)
- Laparoscopy
- Bronchoscopy
- Urology endoscopy (cystoscopy)
- Otoscopy
- Arthroscopy
- Gastrointestinal (GI) endoscopy
- Mediastinoscopy
- Laryngoscopy
- Obstetrics/gynaecology endoscopy
- Others
Endoscopy Devices Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Ambulatory surgery centers
- Hospitals
- Others
Endoscopy Devices Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Endoscopy Devices Market: Product Estimates & Trend Analysis
8. Endoscopy Devices Market: Application Estimates & Trend Analysis
9. Endoscopy Devices Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Endoscopy Devices Market
12. Europe Global Endoscopy Devices Market
13. Asia Pacific Global Endoscopy Devices Market
14. Latin America Global Endoscopy Devices Market
15. MEA Global Endoscopy Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- FUJIFILM Holdings Corporation
- Olympus Corporation
- Richard Wolf GmbH
- PENTAX Medical
- Stryker Corporation
- Smith & Nephew Inc.
- Medtronic Plc (Covidien)
- Karl Storz GmbH & Co. KG
- Ethicon Endo-surgery LLC.
- Boston Scientific Corporation
- Machida Endoscope Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 46.23 Billion |
| Forecasted Market Value ( USD | $ 107.6 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
